Name: MGX Balance Sheet - Metagenomi Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

MGX - Metagenomi Therapeutics, Inc.

USD | NASDAQ | Healthcare

MGX Balance Sheet - Metagenomi Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	41.7	27.4	140.6	-
Restricted Cash	-	-	-	-
Short Term Investments	-	-	-	-
Cash And Short Term Investments	41.7	27.4	140.6	-
Receivables
Accounts Receivable	0.3	1.3	2.5	-
Current Assets
Inventory	-	-	-	-
Prepaid Expenses	4.4	8.4	4.6	-
Other Current Assets	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	28.2	29.0	28.0	-
Accumulated Depreciation	16.0	11.3	6.4	-
Property,Plant & Equipment Net	12.3	17.7	21.5
Current Liabilities
Accounts Payable	1.5	0.5	1.8	-
Short Term Debt	-	-	-	-
Deferred Revenue Current	8.7	22.8	48.1	-
Non-Current Liabilities
Long Term Debt	-	-	-	-
Operating Lease Liabilities Non-Current	34.6	40.2	44.8	-
Deferred Revenue Non-Current	3.0	10.2	30.9
Common Equity
Common Stock	0.0	0.0	0.0	-
Additional Paid In Capital	469.2	457.1	9.5	-
Retained Earnings	(310.9)	(223.0)	(144.9)
Supplementary Data
Total Debt	-	-	-	-
Net debt	-	-	-	-
Working Capital	142.6	220.7	209.4	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	25.3	41.7	32.8	26.9	29.2	27.4	25.1	61.2	102.6	140.6	101.9	51.6	95.7	-
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	25.3	41.7	32.8	26.9	29.2	27.4	25.1	61.2	102.6	140.6	101.9	51.6	95.7	-
Receivables
Accounts Receivable	0.0	0.3	1.0	0.9	0.9	1.1	0.6	1.6	2.1	2.5	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Liabilities
Accounts Payable	2.4	1.5	1.2	2.9	2.7	0.5	3.1	3.5	6.8	1.8	-	-	-	-
Short Term Debt
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)